Importation of US-Authorized Methotrexate for Injection, USP Due to the Current Shortage of Canadian-Authorized Methotrexate Injection BP, 25 mg/mL
In plain language
This recall involves US-authorized Methotrexate for Injection, USP imported into Canada. It's being recalled because there are important differences in dosage, packaging, and reconstitution instructions compared to the Canadian-authorized product. Healthcare professionals should be aware of these differences to prevent medication errors.
What to do
- Stop using the product immediately.
- Check model/serial numbers if provided.
- Return, repair, or dispose of it as instructed.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Methotrexate for Injection, USP
Model: NDC: 63323-122-50
Why this matters
Dosage and packaging differences leading to medication errors
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the model number
Model numbers are typically on the product label or packaging.
Affected models: NDC: 63323-122-50
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Dosage and packaging differences leading to medication errors
What should consumers do?
Stop using the product immediately. Check model/serial numbers if provided. Return, repair, or dispose of it as instructed.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Dosage and packaging differences leading to medication errors
When was this product recalled?
This product was recalled on October 23, 2024.
Is the Methotrexate for Injection, USP brand affected by this recall?
Yes, Methotrexate for Injection, USP products are affected by this recall. This recall involves US-authorized Methotrexate for Injection, USP imported into Canada. It's being recalled because there are important differences in dosage, packaging, and reconstitution instructions compared to the Canadian-authorized product. Healthcare professionals should be aware of these differences to prevent medication errors.